Hepion Pharmaceuticals, Inc.
HEPA· OTC
Filed Nov 13, 2014 · 10-Q · 44 days after period end · 0001104659-14-080146
| Metric | Q1 2015 | Q1 2014 |
|---|---|---|
| Net Income | -$1.47M | — |
| EPS Diluted | -$0.07 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Hepion Pharmaceuticals, Inc. · CIK 1583771 · Engraved from SEC EDGAR
ended Sep 30, 2014 · filed Nov 13, 2014 · 44 d after period end